Islamabad: The Supreme Court of Pakistan (SCP) on Tuesday noted that the recent hike in drug prices by as much as 15 per cent was inevitable and restrained itself from commenting on the matter.
The court heard a case pertaining to the use of substandard stents on the request of National Interventional Cardiology Board (NICB).
NICB lawyer Ali Raza brought to top court’s notice that the government had decided to increase the drug prices by as much as 15 per cent
“The prices of medicines have been jacked-up by 15 per cent this month,” the NICB official told.
Justice Ejaz ul Ahsan said that due to rupee devaluation the price of the medicine went up immeiately.
“Prices cannot stay the same forever; naan used to be of two aanas once, look at its price today”, CJP told Mr Raza.
“We will not comment on this matter”, the CJP remarked.
Chief Justice of Pakistan expressed his disappointment over the failure of producing stents for angioplasty locally, the Chief Justice said that Islamabad’s National University of Science and Technology (NUST) was given millions of rupees by the government to develop a heart stent at a local level which was sent to Germany for testing and no results came from there.
“But to our utter dismay, there are no results so far,” the CJP said.
“Locally produced stent was supposed to be presented in the court today, what happened of it?” CJP Nisar asked Mr Ali Raza, lawyer of NICB, “you had promised that you would produce a stent in the country”, he added.